Fumonisin B1A serine and threonine phosphatase inhibitor

Fumonisin B1 (CAS 116355-83-0)

  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 80ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
5
1
4
0
3
0
2
0
1
0
Sinónimo: Macrofusine
Solicitud: A serine and threonine phosphatase inhibitor
Número de CAS: 116355-83-0
Pureza: ≥98%
Peso Molecular: 721.83
Fórmula Molecular: C34H59NO15
* En el Certificado de Análisis específico de lote, puede encontrar información específica (como el contenido en agua).
Envíe una reseña para este producto y reciba 15 créditos Cruz

Fumonisin B1 is a fungal metabolite produced by Fusarium moniliforme, that has been shown to inhibit protein serine/threonine phosphatases (PP1, PP2A, PP2B, PP2C, and PP5/T/K/H), and is most effective with PP5. It has been shown to stimulate the activation of mitogen-activated protein kinase. Fumonisin B1 has been observed to inhibit sphingolipid biosynthesis, preferentially inhibiting sphingomyelin biosynthesis versus glycosphingolipids in neuronal cells. In primary rat liver cells, fumonisin B1 blocked biosynthesis of de novo sphingolipids through LASS (ceramide synthase) inhibition. Caspase-3 activated or DNA fragmented apoptosis induced by fumonisin B1 binding to a TNF receptor has been documented in many human and rat cell lines. Fumonisin B1 has displayed immunotoxic effects by increasing expression of IL-1β, TNFα, IFN-γ; (interferon γ), IL-1α, IL-6, IL-10, IL-18 and IL-12 in varying mouse cells. Immunotoxicity of fumonisin B1 in human dendritic cells has been demonstrated through expression of chemokine CXCL9 and IFN-γ. Further, fumonisin B1 is an activator of Akt.


References

1. Merrill, A H., et al., 1993. Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ. The Journal of biological chemistry. 268(36): 27299-306. PMID: 8262970
2. Fukuda, H., et al., 1996. Inhibition of protein serine/threonine phosphatases by fumonisin B1, a mycotoxin. Biochemical and biophysical research communications. 220(1): 160-5. PMID: 8602837
3. Wattenberg, E V., et al., 1996. Activation of mitogen-activated protein kinase by the carcinogenic mycotoxin fumonisin B1. Biochemical and biophysical research communications. 227(2): 622-7. PMID: 8878562
4. Merrill, A H., et al., 1996. Fumonisins: fungal toxins that shed light on sphingolipid function. Trends in cell biology. 6(6): 218-23. PMID: 15157459
5. Tripathy, Sandeep K., et al., 2008. Continuous engagement of a self-specific activation receptor induces NK cell tolerance. The Journal of experimental medicine. 205(8): 1829-41. PMID: 18606857
6. Stockmann-Juvala, H., et al., 2008. A review of the toxic effects and mechanisms of action of fumonisin B1. Human & experimental toxicology. 27(11): 799-809. PMID: 19244287

Estado de Materia :
Solid
Solubilidad :
Soluble in water (25 mg/mL), methanol (10 mg/mL), acetonitrile, and DMSO (10 mM).
ALMACENAMIENTO :
Store at -20° C
Punto de ebullición :
~924.91° C at 760 mmHg (Predicted)
Densidad :
~1.3 g/cm3 (Predicted)
Indice de Refracción :
n20D 1.53
IC50 :
sphinganine N-acyl-transferase(ceramide synthase): IC50 = 0.1 µM; de novo sphingolipid biosynthesis: IC50 = 0.7 µM; protein phosphatases PP5: IC50 = 80 µM; protein phosphatases PP2Cα: IC50 = 300 µM; protein phosphatases PP2A: IC50 = 400 µM; protein phosphatases PP1γ2: IC50 = 500 µM; protein phosphatases PP2B: IC50 = 3000 µM
Valores de pK :
pKa: 3.64, pKb: 9.25
Para Uso Exclusivo en Investigación. No está diseñado para uso en diagnosis o terapia.
WGK Alemania :
3
RTECS :
TZ8350000
PubChem CID :
62314
Indice de Merck :
14: 4289
Número MDL :
MFCD00133349
Número EC :
201-067-0
SMILES :
CCCC[C@H](C)[C@H]([C@@H](C[C@H](C)C[C@H](CCCC[C@H](C[C@@H]([C@H](C)N)O)O)O)OC(=O)C[C@H](CC(=O)O)C(=O)O)OC(=O)C[C@H](CC(=O)O)C(=O)O

Descargar SDS (MSDS)

CERTIFICADO DE ANÁLISIS

Necesita Adobe Acrobat Reader para ver de forma fiable,
imprimir y comentar el documento de PDF

Fumonisin B1  Menciones del Producto

Ver como otros han utilizado Fumonisin B1. Haga click en la entrada de PubMed .

Citaciones 1 a 9 de un total de 9

PMID: # 28645851  Tóth, EA. et al. 2017. Biochim. Biophys. Acta. 1862: 991-1000.

PMID: # 28220271  Almada, M. et al. 2017. Apoptosis. 22: 816-826.

PMID: # 28697598  Zheng, K. et al. 2017. J. Agric. Food Chem. 65: 6625-6637.

PMID: # 28123341  Huang, S. et al. 2017. Int. J. Biol. Sci. 13: 1-12.

PMID: # 27357249  Zhao, H.|Zhao, D.|Jin, H.|Li, H.|Yang, X.|Zhuang, L.|Liu, T.| et al. 2016. Mol Med Rep. 14: 1817-22.

PMID: # 25623391  Clarke, R. et al. 2015. Toxicol. Lett. 233: 278-86.

PMID: # 26503955  Bhat, NM. et al. 2015. J. Immunol. 195: 5178-88.

PMID: # 25110174  Clarke, R. et al. 2014. Toxicon. 90: 70-81.

PMID: # 11053253  Blázquez, C. et al. 2000. FASEB J. 14: 2315-2322.

Citaciones 1 a 9 de un total de 9
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 140ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 31ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;

Santa Cruz Biotechnology, Inc. es un líder mundial en el desarrollo de productos para el mercado de la investigación biomédica. Llámenos gratis al 00 800 4573 8000.
Copyright © 2007-2019 Santa Cruz Biotechnology, Inc. All Rights Reserved."Santa Cruz Biotechnology", y el logo de Santa Cruz Biotechnology, Inc., "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", el logo de San Juan Ranch, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", y "EZ Touch" son marcas registradas de Santa Cruz Biotechnology, Inc. Todas las marcas registradas son propiedad de su respectivo dueño.